GlassScriptPhysician profile
Christopher Wade Babl
NPI 1073660841
$3,822.89
in general payments reported to CMS, 2019-2025
11 companies · $261 in 2025
The $261 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,692 · 2020: $412 · 2021: $120 · 2022: $158 · 2023: $180 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $441.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,519.13 | 2019-2020 | |
| Boston Scientific Corporation | $1,361.12 | 2019-2025 | Intracept |
| Medtronic, INC. | $292.41 | 2023-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Abbott Laboratories | $157.87 | 2020 | |
| Nevro Corp. | $151.16 | 2019-2023 | Senza |
| Bioventus LLC | $120.44 | 2021 | |
| Si-Bone, INC. | $90.64 | 2019 | |
| Spr Therapeutics, INC | $75.37 | 2019-2025 | Sprint Pns System |
| Stryker Corporation | $25.62 | 2019 | |
| Vertiflex, INC. | $16.51 | 2019 | |
| Pfizer INC. | $12.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Babl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.